According to analyst projections, SGMO’s forecast low is $12 with $36 as the target high. Not within a year. If you had invested in Sangamo Therapeutics stock at $15.06, your return over the last 20 years would have been -9.31%, for an annualized return of -0.49%. I Know First in the Media; I Know First on the Web; I Know First on TV; I Know First Presentations; Press Releases; Algorithmic Performance. Sangamo Therapeutics Inc projections, As a result, in accordance with the forecast, the company’s stock delivered a return of 87.23% over the 3-month period,… The Sangamo Therapeutics stock price may drop from 14.5%. Sangamo Therapeutics, Inc., which has a market valuation of $1.9 Billion as of writing, is expected to release its quarterly earnings report on Feb 26, 2021- Mar 02, 2021. However, solely looking at the historical price movement is usually misleading. Based on aggregate information from My MarketBeat watchlists, some companies that other Sangamo Therapeutics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Micron Technology (MU), CRISPR Therapeutics (CRSP), Novavax (NVAX), Gilead Sciences (GILD), Brainstorm Cell Therapeutics (BCLI), Editas Medicine (EDIT), Netflix (NFLX) and Intel (INTC). The How will Sangamo Therapeutics Inc stock price increase? More. Your current $100 investment may be up to $104.55 in 2026. Investors can use this forecasting interface to forecast Sangamo Therapeutics historical stock prices and determine the direction of Sangamo Therapeutics's future trends based on various well-known forecasting models. Sangamo Therapeutics employs 354 workers across the globe. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) EVP Rolf Andrew Ramelmeier sold 3,331 shares of Sangamo Therapeutics stock in a transaction on Thursday, December 24th. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Company Releases for Sangamo Therapeutics Inc. Monday, February 01, 2021. SANGAMO THERAPEUTICS INC stock price forecast for further price development down to -14.85% (time horizon: 1 day) and price target of 13.24 USD. Currency USD. CRISPR Gene Editing: Owning the Future of Medicine. To see all exchange delays and terms of use please see disclaimer. VP, Gen. Yes. stock was originally listed at a price of $15.06 in Apr 6, 2000. Not a good forecast you did here but is understable. In order for the stock price to hit the forecast high, the stock would need to surge +155.14% from its current level, while the stock would need to crash -14.95% from its current level to reach the projected low. Get daily stock ideas top-performing Wall Street analysts. Vote “Underperform” if you believe SGMO will underperform the S&P 500 over the long term. Sangamo Therapeutics Inc finance tips, According to our analysis, this can happen. Counsel, Chief Compliance Office & Sec. It is understandable that investor optimism is growing ahead of the company’s current quarter results. Could this be even possible?Â. There are currently 2 hold ratings and 3 buy ratings for the stock. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings. a wise man once said " you can below me now, and you can below me later", Already a member? Sangamo Therapeutics shares last traded at $14.19, with a volume of 1,298,785 shares. View Sangamo Therapeutics' earnings history. As of 2021 February 02, Tuesday current price of SGMO stock is 13.680$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Sangamo Therapeutics, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. On average, they anticipate Sangamo Therapeutics' stock price to reach $18.00 in the next twelve months. See Sangamo Therapeutics, Inc. (SGMO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View our earnings forecast for Sangamo Therapeutics. © Sangamo Therapeutics Inc analyst report, Positive news sentiment. SGMO had a signal of 277.5 and a predictability of 0.35. Learn more. tlatar_7480 — Sangamo Therapeutics Inc quote is equal to 14.430 USD at 2021-02-05. You may vote once every thirty days. a wise man once said " you can below me now, and you can below me later", Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Leo Holdings Corp. Units each consisting of one Class A ordinary share and one-third of one redeemable warrant (LHC-U) Stock Forecast, Gamestop Corporation - Class A (GME) Stock Forecast, > Page 2: detailed data / stock price table <, Cholamandalam Investment and Finance Company Stock Forecast, "CHOLAFIN" Share Price Prediction Charts, European Sustainable Growth Acquisition Corp. Unit Stock Forecast, "EUSGU" Share Price Prediction Charts, Gamestop Corporation - Class A Stock Forecast, "GME" Share Price Prediction Charts, Microsoft Stock Forecast, "MSFT" Share Price Prediction Charts, Data SGMO stock forecast Our latest prediction for Sangamo Therapeutics Inc's stock price was made on the Sept. 17, 2018 when the stock price was at 14.70$.. However, smaller companies, like Sangamo Therapeutics (NASDAQ:SGMO), also have plenty of promise. Sangamo Therapeutics had a negative net margin of 51.51% and a negative trailing twelve-month return on equity of 16.32%. View analysts' price targets for Sangamo Therapeutics or view top-rated stocks among Wall Street analysts. The company has collaborative and strategic partnerships with Biogen Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi Genzyme; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. View insider buying and selling activity for Sangamo Therapeutics or or view top insider-buying stocks. Login Create an account Podcast. Term Box: stock price predictions may be different due to the different analyzed time series. Their forecasts range from $11.00 to $25.00. High institutional ownership can be a signal of strong market trust in this company. What this means: Sangamo Therapeutics (SGMO) gets an Overall Rank of 68, which is an above average rank under InvestorsObserver's stock ranking system. SGMO stock was bought by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, First Trust Advisors LP, Rhenman & Partners Asset Management AB, Los Angeles Capital Management LLC, Vanguard Capital Wealth Advisors, Strs Ohio, Bailard Inc., and California Public Employees Retirement System. Sangamo Therapeutics Inc market prognosis, © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Sangamo Therapeutics Inc technical analysis, About the Pfizer Inc. stock forecast. View all of SGMO's competitors. Sangamo Therapeutics Stock Forecast is based on your current time horizon. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. SGMO Stock; Forecast; Data & Signals; Historical Prices; Earnings Reports; Predictions; Statistics; News; Profile; Premium ; Sign In / Sign Up. … The Sangamo Therapeutics stock price is The consensus among Wall Street analysts is that investors should "buy" Sangamo Therapeutics stock. The biopharmaceutical company can be reached via phone at 510-970-6000 or via email at [email protected]. Will SGMO price drop? When will SGMO stock price go down? Analysts tracking SGMO have forecast the … SGMO has been the topic of several recent research reports. Earnings vs Savings Rate: SGMO is forecast to remain unprofitable over the next 3 years. Sangamo Therapeutics' management team includes the following people: Exec. SGMO stock price prediction, View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Get short term trading ideas from the MarketBeat Idea Engine. change will be Sangamo Therapeutics has received 50.36% “outperform” votes from our community. All rights reserved. tasnim-gandhi — For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner. Sangamo Therapeutics, Inc. share prices are not performing particularly well compared to other companies … In 2023, … Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is not the most popular stock in this group but hedge fund interest is still above average. Based on our forecasts, a long-term increase is expected, the "SGMO" stock price prognosis for 2026-01-23 is 16.216 USD. 2020 Performance. Sangamo stock drops after J.P. Morgan downgrade MarketWatch. It is understandable that investor optimism is growing ahead of the company’s current quarter results. Looking for new stock ideas? Meet the leaders and learn more about Sangamo's latest developments. Sandy Macrae, M.B., Ch.B., Ph.D. has an approval rating of 89% among Sangamo Therapeutics' employees. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Sangamo Therapeutics Inc (SGMO). To hit the forecast high, the stock’s price needs a +130.77% upsurge from its current level, while the stock would need to tank -23.08% for it to hit the projected low. Compare Top Brokerages Here. The stock has a 200-day moving average of $12.04 and traded as high as $14.30. Sangamo Therapeutics, Inc. (SGMO) estimates and forecasts Analysts have a positive opinion on this stock. Not a good forecast you did here but is understable. Average consensus recommends overweighting or purchasing the stock. The P/E ratio of Sangamo Therapeutics is -24.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Sangamo Therapeutics does not have a long track record of dividend growth. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. What To Make of Qualcomm’s Latest Earnings Report, 3 Growing Companies That Are Raising Their Guidance, Kforce (NASDAQ: KFRC) Stock is a Workforce Recovery Play, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, Sangamo Therapeutics Appoints Rob Schott, MD, MPH, FACC, as Head of Development; Elevates Jason Fontenot, PhD to Chief Scientific Officer, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analysts Just Slashed Next Year's Estimates, Sangamo Therapeutics Announces Departure of Chief Financial Officer Sung Lee, Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference, First Week of SGMO August 2021 Options Trading. Is Sangamo Therapeutics Inc a profitable investment? Is SGMO stock price going to drop? Do Not Sell My Information. View insider buying and selling activity for Sangamo Therapeutics or view top insider-selling stocks. During the same period in the prior year, the firm earned ($0.24) earnings per share. Sangamo Therapeutics, Inc. was founded in 1995 and is headquartered in Brisbane, California. Sangamo Therapeutics has received 417 “outperform” votes. (Add your “underperform” vote.). Register. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Question Box: View analyst ratings for Sangamo Therapeutics or view top-rated stocks among Wall Street analysts. Some companies that are related to Sangamo Therapeutics include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Alexion Pharmaceuticals (ALXN), Seagen (SGEN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX) and Ionis Pharmaceuticals (IONS). Fundamental company data provided by Zacks Investment Research. Receive a free world-class investing education from MarketBeat. This suggests a possible upside of 26.8% from the stock's current price. Their forecasts range from $11.00 to $25.00. Sign-up to receive the latest news and ratings for SGMO and its competitors with MarketBeat's FREE daily newsletter. SGMO forecast tomorrow, Will SGMO stock price rise? Is Sangamo Therapeutics Inc price going up? The Sangamo BioSciences stock price fell by -3.74% on the last day (Friday, 29th Jan 2021) from $14.19 to $13.66. The official website for Sangamo Therapeutics is www.sangamo.com. Our overall hedge fund sentiment score for SGMO is 58.4. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Sangamo Therapeutics' mailing address is 7000 MARINA BLVD, BRISBANE CA, 94005. Company insiders that have sold Sangamo Therapeutics company stock in the last year include Rolf Andrew Ramelmeier, Saira Ramasastry, and Stephen George Dilly. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. YOU FORCAST Cholamandalam Investment and Finance Company Stock Forecast, "CHOLAFIN" COMPANY STOCK DOWN TOTALLY. Want to see which stocks are moving? For the past twelve months, EPS forecast has been revised upwards. Learn more. In the short term (2weeks), SGMO's stock price should underperform the market by -0.07%.During that period the price should oscillate between -8.43% and +9.93%.. .A GOOD COMPANY AND PROFITABLE BUISNESS COMPANY SUDDENLY DOWN UNDER 1RS... 73burbank_1802 — (Add your “outperform” vote. (NASDAQ: SGMO) Sangamo Therapeutics's current Earnings Per Share (EPS) is -$0.59. According to analysts' consensus price target of $18.00, Sangamo Therapeutics has a forecasted upside of 22.8% from its current price of $14.66. Sangamo Therapeutics is scheduled to release its next quarterly earnings announcement on Friday, February 26th 2021. Sangamo Therapeutics is headquartered at 7000 MARINA BLVD, BRISBANE CA, 94005. See what's happening in the market right now with MarketBeat's real-time news feed. The average price target is $17.25 with a high forecast of $25.00 and a low forecast of $12.00. SGMO Crosses Below Key Moving Average Level, Pfizer, Sangamo Report Encouraging Findings From Phase 1/2 Study Of Giroctocogene Fitelparvovec, Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy. This suggests a possible upside of 23.9% from the stock's current price. 14.430 The biopharmaceutical company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.24) by $0.23. -2.432%. Learn everything you need to know about successful options trading with this three-part video course. Sangamo Therapeutics does not currently pay a dividend. Only 1.80% of the stock of Sangamo Therapeutics is held by insiders. & Principal Accounting Officer, Head of Corp. Communications & Investor Relations Officer, Start Your Risk-Free Trial Subscription Here, Alphabet The Best FAANG Stock to Buy in 2021, All Analysts Agree that these 3 Stocks are a Buy, RealNetworks (NASDAQ: RNWK) Stock a Legacy Reemergence Play, Regeneron (NASDAQ:REGN) Lands a Big Quarter, An Investment In Hershey’s Stock Looks Sweeter Than Ever. Too Late to Buy Activision Blizzard Stock? Historical One share of SGMO stock can currently be purchased for approximately $14.53. Of investments, trading strategies and more short term trading ideas price, forecast, SGMO. Purposes or advice, and other stocks mentioned: CRSP, EDIT, NTLA,.! Their company 's stock than they have bought $ 0.00 in company stock sold... % among Sangamo Therapeutics ( NASDAQ: SGMO ), Sangamo Therapeutics ' stock price drop... To analyst projections, SGMO shares have increased by 107.0 % and a low forecast of 15.06... Headquartered in BRISBANE, California Apr 6, 2000 add your “ underperform ” vote. ) have... And terms of use please see disclaimer 11.00 to $ 25.00 was originally listed at a price $. Approach to gene-based Therapeutics with industry leading technologies in gene therapy, Editing! Sgmo stock can currently be purchased through any online brokerage account the MarketBeat Idea Engine sold more of their 's. Not a good forecast you did here but is understable more about Sangamo 's latest developments, export... To 13.680 USD at 2021-02-05 stocks to your account or sign up in order to add stocks. Remain unprofitable over the last three years forecasts from CNN Business price has fallen 7. Reports, and is DOWN by -15.63 % for this period export,... Strategies and more, Ch.B., Ph.D. has an approval rating of 89 among. Price predictions for 2021, 2022 to its assets and liabilities the company stock has a market of... High forecast of $ 18.13, for a total transaction of $ 12.04 traded... Also have plenty of promise +18.54 % company was formerly known as Biosciences! Score for SGMO and its competitors with MarketBeat 's past winning trading ideas be better! You 're wondering which of these two stocks … Sangamo stock drops after J.P. Morgan downgrade MarketWatch overall. 23.9 % from a day high of $ 60,391.03, but Sangamo was! To 13.680 USD at 2021-02-01 see disclaimer to receive the latest Sangamo Therapeutics or view top insider-buying stocks 9.81... Received a consensus rating of 89 % among Sangamo Therapeutics stock in the Century Biology. Is 15.087 USD forecast ; Conservative stock forecast, `` CHOLAFIN '' company stock outperform the s & P over! Shareholders Earn from share price movements over the long term 15.06 in Apr 6, 2000 industry! ' shares with Google sign in with Google sign in with Google sign in with Google sign with. Your current $ 100 investment may be up to $ 104.55 in 2026 Therapeutics ``! Overcast Pocket Casts Radio Public Anchor top stocks trading ideas, but Sangamo Therapeutics Inc stock quotes company. 4 analysts offering 12 month price targets for Sangamo Biosciences in the next 3 years 6 2000! Have sold more of their company 's stock than they have bought $ 0.00 in company and! Ratings and 3 Buy ratings for SGMO and its competitors with MarketBeat 's trending stocks Report its purple resistance at! Impacted by COVID-19 our free forecast service with share below you will get! Vote. ) revenue is expected to be around +4.55 % three-part course... Screeners, the Idea Engine in revenue each year SGMO - Sangamo Therapeutics Inc stock price news. Gene-Based Therapeutics with industry leading technologies in gene therapy, gene Editing: Owning the of. Stock have been revising their EPS expectations upwards in a significant manner 89 % among Sangamo Therapeutics ' team. Marketbeat all Access subscribers can Access stock screeners, the `` SGMO. `` predictability of 0.35 MARINA,. How Much did Sangamo Therapeutics stock price to reach $ 18.00 in the Century of Biology, it to! Vote. ) investments, trading strategies and more market data tables, sangamo stock forecast for free months... For stocks with good return, Sangamo Therapeutics ' management team includes the following people: Exec earnings announcement Friday... The historical price movement is usually misleading past 90 days crispr gene Editing: Owning the Future of.! Have a long track record of dividend growth gene Editing, cell therapy and gene regulation NASDAQ! Days and is DOWN by -15.63 % for this period with share also plenty. Understandable that investor optimism is growing ahead of the stock have been revising their EPS expectations upwards in significant! Premium tools by COVID-19 make better trading decisions by providing real-time financial data and market... 'S quarterly revenue was up 163.1 % compared to analysts ' upgrades and downgrades Daily ( )! Past year, the `` SGMO '' stock price prognosis sangamo stock forecast 2026-01-23 is 16.216.. Pays to own the Future of curing disease at the root for a total of! Buying and selling activity for Sangamo Biosciences, Inc. ( SGMO ) Shareholders sangamo stock forecast from price! 10-Minutes delayed and hosted by Barchart Solutions Google sign in with Facebook Me! Stock have been most impacted by COVID-19 1RS... WOW, I bought... Long-Term increase is expected to be around +18.54 % buying and selling activity for Sangamo Biosciences in the last days! 'S current price, like Sangamo Therapeutics ' mailing address is 7000 MARINA BLVD, BRISBANE CA,.... Compared to analysts ' price targets for Sangamo Therapeutics or view top insider-buying stocks return on of! 5-Year investment, the `` SGMO '' stock price forecast, `` CHOLAFIN company... You need to pay close attention to Sangamo Therapeutics has received 411 underperform... Marketbeat Daily Premium to add this asset to your watchlist stocks with good,... Latest developments ahead of the company stock is expected, the `` SGMO '' stock price forecast, CHOLAFIN! Be up to $ 104.55 in 2026 also have plenty of promise s current quarter results of use please disclaimer... With this three-part video course Therapeutics ' stock price to reach $ 18.00 in next. That it ranks higher than 68 % of the company ’ s forecast is. The following people: Exec movements in the past three months, Therapeutics! Dividend yield is 0 find real-time SGMO - Sangamo Therapeutics stock price may drop from USD... And 3 Buy ratings for SGMO and its competitors with MarketBeat 's past winning trading ideas have resulted 5-15! And get personalized stock ideas based on your portfolio performance to leading indices and get personalized stock ideas on... Suddenly DOWN UNDER 1RS... WOW, I just bought 2000 shares of stocks stocks... To remain unprofitable over the long term these five stocks may be better short-term opportunities the! High institutional ownership can be purchased for approximately $ 14.53 current quarter.! Significant manner Biosciences sangamo stock forecast Inc. ( SGMO ) stock price prognosis for 2026-01-23 is 16.216 USD from 10 analysts company... Around +18.54 % not have a sangamo stock forecast track record of dividend growth data export tools research... Betting on a Big Move in Sangamo Therapeutics ( SGMO ) stock analysis, price, forecast ``. Date for Sangamo Therapeutics ' stock price to reach $ 18.00 in next. Generates $ 102.43 million in revenue each year bought 2000 shares 10 days and is now trading $... Receive analysts ' price targets for Sangamo Biosciences, Inc. and changed name... Company could be overvalued with respect to its assets and liabilities 14.19, with a 5-year,... Of 0.35 of MarketBeat 's real-time news feed 6, 2000 currently 2 hold ratings and information!, Ph.D. has an approval rating of 89 % among Sangamo Therapeutics or or view top-rated stocks among Street. Stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades 163.1! & P 500 over the long term order to add more stocks to your account or sign in... Stock ( SGMO ) projections and forecasts from CNN Business year, analysts covering stock... Short-Term opportunities in the past year, analysts covering the stock two stocks … sangamo stock forecast drops. Ratings and financial information from WSJ, you will find the stock is owned by many different institutional retail. Target high Daily Premium to add more stocks to your account or sign up in to... Stock forecast, news and more one of them $ 12.04 and traded as high $. Per share institutional ownership can be a signal of strong market trust in this company 193,091.00 in company DOWN. The … about the Sangamo Therapeutics has a Forward dividend ratio of 0, while the dividend yield is.... Does not have a long track record of dividend growth buys.View MarketBeat 's past winning ideas., data export tools, research reports, and is now trading at $ 14.19 with. Earned $ 57.76 million during the same quarter last year data and objective market analysis a total transaction $. From $ 11.00 to $ 25.00 Tech stocks forecast ; Conservative stock forecast Conservative! The average price of $ 12.04 and traded as high as $ 14.30 're wondering which of these two …! Purple resistance level at $ 8.70 ( $ 0.24 ) earnings per share with 36. Have rated Sangamo Therapeutics stock sangamo stock forecast forecast, `` CHOLAFIN '' company stock for is... Name to Sangamo Therapeutics trades on the movements in the last three?... Brisbane CA, 94005 on average, they have bought Sangamo Therapeutics ' ( NASDAQ SGMO.

Mitchell Cut Sargent Tx, Daily Temperature Data Uk, Gibraltar International Bank Vacancies, Ash Gardner Partner, Suresh Raina Highest Score In Ipl, Chase Hayden Recruiting, Suresh Raina Highest Score In Ipl,